BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 22, 2017
View Archived Issues
FDA grants alirocumab orphan status for homozygous familial hypercholesterolemia
Read More
Apatinib mesylate receives U.S. orphan designation for treating gastric cancer
Read More
Burosumab granted FDA orphan drug status for tumor-induced osteomalacia syndrome
Read More
Sirnaomics' cotsiranib receives U.S. orphan status for primary sclerosing cholangitis
Read More
Porton Biopharma and NanoBio to advance intranasal anthrax vaccine
Read More
Leap Therapeutics to collaborate with Merck for evaluation of Keytruda in combination with DKN-01
Read More
First patient enrolled in a clinical trial evaluating treatment for mycetoma in Sudan
Read More
Daiichi Sankyo describes promising candidate for urinary tract infections, DS-86760016
Read More
Anti-KIR3DL2 monoclonal antibody IPH-4102 receives U.S. orphan designation
Read More
FDA names mirikizumab an orphan drug for the treatment of pediatric ulcerative colitis
Read More
Merck & Co. presents phase Ib results for rVSVdeltaG-ZEBOV-GP Ebola virus vaccine
Read More
Athera Biotechnologies' PC-mAb named U.S. orphan drug as company completes multiple-dosing study
Read More
GSK presents results from phase III study of revaccination with Shingrix
Read More
Preclinical data support entry of GyrB inhibitor DS-2969b into phase I development
Read More
EMA accepts Novartis' MAA filing for erenumab
Read More
Phase III cardiovascular risk reduction study of ACZ-885 meets primary endpoint
Read More
Identification of human MDA5 deficiency as a novel inborn error of innate and/or intrinsic immunity
Read More
Janssen enters agreement to use Adaptive Biotechnologies' assay in daratumumab studies
Read More
Sphingosine-1-phosphate is a potential marker of cystic fibrosis genotypes and presentation
Read More
GlaxoSmithKline describes novel hSTING modulators
Read More
CSIR identifies new CDK2/cyclin A and CDK9/cyclin-T1 inhibitors
Read More
Merck & Co. patents novel beta-secretase 1/2 inhibitors
Read More
Infuseon and OncoSynergy partner to test OS-2966 with Cleveland Multiport Catheter in glioblastoma
Read More
FDA gives orphan drug designation to pamrevlumab for pancreatic cancer
Read More
Kadimastem receives IRB approval for phase I/IIa trial of AstroRx in ALS
Read More
Novel mutation in INS gene tied to hereditary diabetes
Read More
DiAPREV-IT trial: first data for Alum-GAD for prevention of type 1 diabetes
Read More
FDA grants orphan drug designation to ibutamoren mesilate for growth hormone deficiency
Read More
EMA validates Veyvondi MAA
Read More